The Ritedose Corporation: Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 individually wrapped vials (NDC 76204-030-01) and 60 individua
- Recall status
- Ongoing (still active)
- Severity
- Class II: could cause temporary or reversible health problems What recall classes mean
- Where sold
- Nationwide within the U.S
Common questions
- Is The Ritedose Formoterol Fumarate Inhalation Solution 20mcg/2mL recalled?
- Yes. FDA (drug) recalled The Ritedose Formoterol Fumarate Inhalation Solution 20mcg/2mL on 2026-11-04. Recall status: Ongoing (still active).
- What is the hazard?
- Failed Impurities/Degradation Specification
- Where was it sold?
- Nationwide within the U.S
Read the official notice at FDA (drug) →
More recalls
- bioQuad Life Sciences: OsteoDenx capsules
- Game Changer Products, LLC: 10 Day Forecast Capsules 3200mg
- Eugia US LLC: Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single
- Trifluent Pharma LLC: Tridacaine III / Lidocaine Patch 5%, 15 envelopes
- MSN Laboratories Private Limited (Formulations Division, Unit-II): Atorvastatin
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- The Ritedose Corporation
- Product
- Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 individually wrapped vials (NDC 76204-030-01) and 60 individually wrapped vials (NDC 76204-030-02), Rx only, Manufactured for and by: Ritedose Pharmaceuticals, LLC, Columbia, SC
- Reason / hazard
- Failed Impurities/Degradation Specification
- What to do (remedy)
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Nationwide within the U.S
- Recall initiated
- 2026-10-15
- Code info
- Lot: 25BL0, Expires: 02/28/2027
- Product quantity
- 3210 Cartons
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Columbia
- State
- SC
- Country
- United States
- Event id
- 100124
Free daily digest + "My products" watchlist